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Cell-fusion-mediated somatic-cell reprogramming
can be induced in culture; however, whether this
process occurs in mammalian tissues remains enig-
matic. Here, we show that upon activation of Wnt/
b-catenin signaling, mouse retinal neurons can be
transiently reprogrammed in vivo back to a precursor
stage. This occurs after their spontaneous fusionwith
transplanted hematopoietic stem and progenitor
cells (HSPCs). Moreover, we demonstrate that retinal
damage is essential for cell-hybrid formation in vivo.
Newly formed hybrids can proliferate, commit to dif-
ferentiation toward a neuroectodermal lineage, and
finally develop into terminally differentiated neurons.
This results in partial regeneration of the damaged
retinal tissue,with functional rescue. Following retinal
damage and induction of Wnt/b-catenin signaling,
cell-fusion-mediated reprogramming also occurs
after endogenous recruitment of bone-marrow-
derived cells in the eyes. Our data demonstrate that
in vivo reprogramming of terminally differentiated
retinal neurons after their fusion with HSPCs is a
potential mechanism for tissue regeneration.
INTRODUCTION
The nucleus of a differentiated cell can be reprogrammed in vitro
back to a pluripotent phenotype by ectopic overexpression of
some defined stem cell factors, by nuclear transfer, or by cell
fusion with embryonic stem cells (ESCs). Modulation of signaling
pathwayssuchas thoseofWnt/b-catenin,MAPK/ERK, andPI3K/
Akt can strikingly enhance reprogramming activity (Lluis and
Cosma, 2009, 2010). Cell fusion is a well-known mechanism to
change the potency of differentiated cells in vitro (Blau et al.,
1983, 1985). Polyethylene glycol (PEG)-mediated embryonic-germ/thymocyte or ESC/thymocyte hybrids show reactivation
of theOct4-GFP transgene aswell as erasure of DNAmethylation
associated with imprinted genes and reactivation of the inactive
X chromosome. Notably, hybrid cells can differentiate toward
the three germ layers (Tada et al., 1997; Tada et al., 2001). Simi-
larly, human fibroblasts can be reprogrammed to pluripotency in
hybrids formed with human ESCs (Cowan et al., 2005).
Remarkably, coculture of ESCs with neural stem cells or with
bone marrow cells (BMCs) leads to spontaneous formation of
tetraploid hybrids with a pluripotent phenotype (Terada et al.,
2002; Ying et al., 2002). We reported that the periodic accumu-
lation of b-catenin in the ESC nucleus up to a specific threshold
enhances the efficiency of ESCs to reprogram somatic cells after
fusion (Lluis et al., 2008). Of note, Wnt-dependent reprogram-
ming occurs efficiently also after spontaneous cell-cell fusion
(Lluis et al., 2010).
Cell-cell fusion is a physiological mechanism that controls
developmental processes, such as fertilization and muscle and
bone development (Sullivan and Eggan, 2006); moreover, it can
also occur in vivo after bone marrow (BM) transplantation, both
in mice and in humans. Indeed, transplanted hematopoietic cells
can fuse to hepatocytes, cardiomyocytes, and Purkinje cells,
which leads to the formation of stable heterokaryons and syn-
karyons (i.e., hybrids with one or two nuclei), in different organs
(Ogle et al., 2005). Hematopoietic cells can naturally fuse with
human Purkinje cells in vivo (Weimann et al., 2003). These fusion
events have been shown to increase after injury and inflamma-
tion, such as in the case of fusion between BM-derived cells
and Purkinje neurons in the cerebellum of mice (Johansson
et al., 2008) or in the caseof fusion of lymphoid andmyeloid blood
cells with cells from different tissues (Nygren et al., 2008).
These findings prompted us to determine whether stem and
progenitor cells (SPCs) can fuse with retinal neurons and Mu¨ller
glia after their transplantation in damaged retinas and whether
the in-vivo-formed hybrids can undergo reprogramming.
Furthermore, our aim was to investigate whether activation of
Wnt/b-catenin signaling pathway can trigger the reprogramming
process in vivo. Finally, we wanted to investigate whetherCell Reports 4, 271–286, July 25, 2013 ª2013 The Authors 271
cell-fusion-mediated reprogramming is a mechanism of nervous
tissue regeneration.
Wnt-secreted glycoproteins are morphogens that control a
variety of different developmental processes and cell homeosta-
sis mechanisms, such as cell proliferation, cell polarity, stem
cell self-renewal, and cell-fate determination, in embryonic life
(Logan and Nusse, 2004). After binding of Wnt ligands with
receptor, Frizzled (Fz), and coreceptor, lipoprotein-receptor-
related proteins 6 and 5 (LRP6/5), the b-catenin destruction
complex is inactivated. The destruction complex includes the
tumor suppressor adenomatous polyposis coli (APC), the scaf-
fold protein Axin2, casein kinase 1 (CK1), and glycogen synthase
kinase 3 (GSK3). Its function is to phosphorylate b-catenin
through CK1 andGSK3. After that, the phosphorylated b-catenin
can be ubiquitinated and degraded via the activity of the proteo-
some (MacDonald et al., 2009). In a recent study, it was shown
thatWnt signaling does not induce inactivation of the destruction
complex but rather suppresses b-catenin ubiquitination (Li et al.,
2012). In both models, after Wnt binding to its receptor, b-cate-
nin is stabilized and can translocate into the nucleus, where it can
activate target genes.
To test our hypothesis, we choose the eye as model system.
Notably, the eye is an isolated organ that shows low immune
responses to cells and viral vectors (Streilein et al., 2002); in addi-
tion, the confined space allows injection of a small number of
cells. Moreover, the retina is the most accessible area of the
CNS, andwewanted to determinewhether neurons can undergo
fusion with BM-derived cells and reprogramming.
Here, we show that upon retinal damage induced by injection
of the glutamate receptor antagonist N-methyl-D-aspartate
(NMDA) into the vitreous, transplanted SPCs, such as mouse
hematopoietic stem and progenitor cells (mHSPCs), human (h)
HSPCs, retinal (R)SPCs, and ESCs, can fuse with retinal neurons
in vivo with high efficiency. Importantly, we show that the fate of
these hybrids is to embark upon apoptosis unlessWnt/b-catenin
signaling is activated in the transplanted cells. Indeed, the acti-
vation of theWnt pathway induces reprogramming of retinal neu-
rons back to precursor or embryonic stages after HSPC or ESC
fusion, respectively. HSPC-derived reprogrammed hybrids can
proliferate and in turn differentiate into ganglion and amacrine
neurons, thereby contributing to retinal regeneration. Remark-
ably, multielectrode recordings of retinal explants showed
functional rescue of ganglion neurons to light response in the
regenerated retinas. Finally, we also show fusion and reprogram-
ming of retinal neurons after endogenous recruitment of BMCs in
damaged retinas.
In conclusion, we show here that upon NMDA-induced retinal
damage, Wnt/b-catenin-mediated reprogramming of terminally
differentiated cells, such as retinal neurons, can occur in vivo.
This represents a way to promote cell and tissue regeneration
in mammals.
RESULTS
NMDA-Induced Injury Triggers Fusion between Retinal
Neurons and SPCs
Following BM transplantation, hematopoietic cells can fuse to
different somatic cells in vivo, which can contribute to the repair272 Cell Reports 4, 271–286, July 25, 2013 ª2013 The Authorsof tissues, although with low efficiency (Alvarez-Dolado et al.,
2003; Nygren et al., 2008; Ogle et al., 2005; Vassilopoulos and
Russell, 2003; Wang et al., 2003). However, it remains to be
seen if retinal damage can enhance fusion efficiency of BM cells
and if neurons can thereby be reprogrammed within retinas of
adult vertebrates.
Thus, we first investigated whether as a consequence of a
retinal injury BM-derived HSPCs can fuse with neurons in the
retina, which represents the simplest CNS tissue (Figure S1A).
With this aim, we induced retinal damage by injecting NMDA
into the vitreous of transgenic mice carrying a LoxP-STOP-
LoxP-YFP [R26Y] allele. We left the contralateral eyes undam-
aged as the controls. NMDA caused apoptosis of the ganglion
and amacrine neurons of the retina (Figure S1B), as shown
previously (Osakada et al., 2007), but not the incidental expres-
sion of yellow fluorescent protein (YFP) (Figure S1C). Then,
HSPCsCre/RFP (HSPCs expressing Cre recombinase and red
fluorescent protein [RFP]) isolated from CRE-RFP double-trans-
genic donor mice were transplanted in both R26Y eyes. The
retinas were harvested 24 hr after transplantation. In the case
of fusion between the injected HSPCsCre/RFP and R26Y retinal
neurons, we would expect expression of YFP in hybrid cells
due to the stop codon excision by Cre (Figure 1A).
In the damaged eyes, a large number of YFP+/RFP+ hybrids
were seen in retinal flat mounts. In contrast, there were no
YFP+ hybrids in the contralateral, nondamaged retinas (Fig-
ure 1B). Fusion efficiency between the transplanted HSPCs
and retinal cells was evaluated in different ways. We counted
the number of hybrids in vertical sections in the area of damage;
i.e., in the ganglion cell layer and the inner nuclear layer of the
retinal tissue. On average, we obtained 6.5% YFP+/RFP+ cells
with respect to the total 5 3 105 injected RFP+ cells (Table S1);
however, this percentage was increased to 70% when we eval-
uated the number of YFP+/RFP+ cells relative to the total RFP+
cells in the area of damage (Figures S2A and S2B). In addition,
fusion was evaluated and confirmed by fluorescence-activated
cell sorting (FACS) analysis (Figure S2C). Tetraploid cells, which
contained double content of DNA (4C), were also present in high
amount, as analyzed by flow cytometry (Figure S2D). Further-
more, some of the hybrids were heterokaryons (Figure S2E).
These data demonstrated tissue-damage-induced fusion
between HSPCs and retinal cells.
We then askedwith which retinal cells the transplantedHSPCs
had fused. Thus, we analyzed the expression of different retinal
cell markers in YFP+ hybrids. The hybrids were positive forMu¨ller
glia (GS), amacrine (Chat), and ganglion (SMI-32) cell markers
(Figures 1C–1E), which indicated that the injected HSPCs fused
with these types of retinal cells. In addition, we transplanted DiD-
labeled HSPCsR26Y (HSPCs expressing the R26Y allele labeled
with the red membrane dye DiD) into the damaged eyes of
GFAP-Cre and CALR-Cre transgenic mice as lineage-tracing
mouse models for Mu¨ller and amacrine/ganglion cells, respec-
tively. A significant percentage of DiD+/YFP+ hybrids were
seen in both models, further confirming the fusion of Mu¨ller
glia, amacrine, and ganglion neurons with HSPCs (Figures S2F
and S2G).
Finally, we also investigated whether different stem cell types
transplanted in the damaged eyes could fuse with retinal
Figure 1. NMDA Retinal Damage Induces Cell Fusion In Vivo
(A) Schematic representation of the cell fusion experimental plan. In vivo cell fusion between HSPCsRFP/Cre and retinal neurons of LoxP-STOP-LoxP-YFP mice
(R26Y) leads to excision of a floxed stop codon in the retinal neurons and, in turn, to expression of YFP. The resulting hybrids express both YFP and RFP.
(B) Confocal photomicrographs of flat-mounted retinas focused on the gcl of R26Y NMDA-damaged (NMDA) or healthy (control) eyes of mice transplanted with
HSPCsRFP/Cre harvested 24 hr after transplantation. Double-positive RFP (red) and YFP (green) hybrids derived from cell fusion are detected in the presence of
NMDA damage (NMDA) but not in the undamaged eye (control). Nuclei were counterstained with DAPI (blue). Scale bar: 50 mm.
(C–E) Immunohistochemical analysis of the retinal fusion cell partners. YFP+ hybrids positive for Mu¨ller glia (C, GS, red), amacrine (D, Chat, red) or ganglion
(E, SMI-32, red) cell markers are detected 24 hr after transplantation of HSPCsCre in NMDA-damaged eyes. Yellow arrows indicate cells positive to both YFP and
marker staining. Scale bar: 50 mm.
See also Figures S1, S2, and S3.neurons. Thus, we performed similar experiments by injecting
DiD-labeled RSPCsCre isolated from the ciliary margin of Cre
transgenic mouse eyes and DiD-labeled ESCsCre into the
undamaged and NMDA-damaged eyes of the R26Y mice. Both
cell types fusedwith the retinal cells with good efficiency (FiguresS3A–S3C). Furthermore, we also confirmed that ESCsCre fused
with Mu¨ller glia, amacrine, and ganglion neurons (Figures S3D
and S3E). Overall, our data demonstrate that HSPCs, ESCs,
and RSPCs can fuse with retinal neurons in vivo upon cell
damage.Cell Reports 4, 271–286, July 25, 2013 ª2013 The Authors 273
(legend on next page)
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The Wnt/b-Catenin Signaling Pathway Triggers
Reprogramming of Retinal Neurons In Vivo
We previously showed that activation of Wnt signaling triggers
cell-fusion-mediated reprogramming of neural precursor cells
in culture (Lluis et al., 2008, 2011). With this in mind, we tested
whether HSPC/retinal-neuron hybrids were reprogrammed after
Wnt/b-catenin pathway activation soon after the injection of the
cells. Untreated HSPCsCre/RFP and HSPCsCre/RFP in which the
Wnt signaling pathway had been previously activated by
the GSK-3 inhibitor 6-bromoindirubin-30-oxime (BIO) (Fig-
ure S4A) were injected into the NMDA-damaged eyes of R26Y
mice. Twenty-four hours later, we sorted the hybrids from the
retinas by FACS and analyzed the expression of precursor and
embryonic genes by real-time PCR.
In the FACS-sorted RFP+/YFP+ BIO hybrids (hybrids formed
after transplantation of BIO-HSPCs), Oct4, Nanog, SSEA1 (plu-
ripotency genes), Nestin, Otx2, Noggin, and Six3 (neural precur-
sor genes) were all activated (Figure 2A); expression of these
genes was not detectable in the nontransplanted NMDA-injured
retinas or in the BIO-treated or untreated HSPCs (Figures S4B
and S4C). In contrast, the neuron-specific markers Calr and
Brn3b, the Mu¨ller glial marker GFAP, and the HSPC-specific
gene CD34 were downregulated (Figure 2A). None of the precur-
sor/pluripotency markers were expressed in No-BIO hybrids
(hybrids formed after transplantation of untreated HSPCs) (Fig-
ure 2A). These data suggested that the BIO hybrids were reprog-
rammed, as precursor/ pluripotent genes were expressed and
differentiation markers were downregulated.
To further demonstrate the activation of an in vivo reprogram-
ming process, we analyzed the reactivation of the Nanog and
Nestin promoters in adult retinas. We used two different mouse
models as recipients: Nestin-Cre (transgenic mice expressing
Cre recombinase gene under the control of Nestin promoter in
neural precursors) and Nanog-GFP-Puro mice (transgenic mice
expressing GFP-puromycin transgenes under the control of the
Nanog promoter in the embryo), which allowed us to investigate
reprogramming at the neuronal precursor and the embryonic
stages, respectively. Therefore, we transplanted HSPCsR26Y/RFP
into NMDA-damaged eyes of Nestin-Cre mice. Likewise, we
transplanted HSPCsRFP into NMDA-damaged eyes of Nanog-
GFP mice (Figures 2B and 2E). NMDA was injected intravitreally
into one eye of a group of mice, while the contralateral eyes
remained undamaged as the controls. Importantly, NMDA alone
did not activate the transgene expression (Figure S4D). The ret-
inas were harvested 24 hr after cell transplantation. In the case ofFigure 2. Activation of the Wnt Signaling Pathway Enhances Neuron R
(A) Gene expression profile of fluorescence-activated cell sorted RFP+/YFP+ hy
(black bars) HSPCsCre/RFP in R26Y NMDA-damaged eyes. Data are real-time P
complementary DNAs of NMDA-damaged retinas mixed with either untreated H
(B and E) Schemes of cell-fusion-mediated reprogramming to identify Nestin (B)
(C and F) Double-red+/green+-reprogrammed hybrids were detected only in the
HSPCsR26Y/RFP in Nestin-Cre (C) and HSPCsRFP in Nanog-GFP (F) eyes. Scale b
(D and G) Quantification of double-red+/green+ hybrids activating Nestin (D) a
Undamaged or NMDA-damaged retinas treated or not with DKK1were transplante
HSPCs. Data are mean ±SEM (n = 90) counted in vertical sections (as for Figure
(H and I) Mouse (H) and human (I) gene expression profiles of fluorescence-activ
CD34+ HSPCs in NMDA-damaged eyes of Nanog-GFP mice. Data are mean ±S
See also Figures S4, S5, S6, S7, and S8.reprogramming of the retinal neurons, in these mouse models,
we would expect to find double-red/green-positive cells (Figures
2B and 2E).
In both mouse models, in flat-mounted retinas, we found a
high number of green+/red+ hybrids, which indicated the reacti-
vation of both Nanog and Nestin promoters (Figures 2C and 2F).
To evaluate the efficiency of this in vivo reprogramming, we
counted the green-positive reprogrammed cells relative to
the total injected red-HSPCs and relative to the red-HSPCs
detected in the ganglion cell layer and the inner nuclear layer
of the retinal tissue. A percentage of red cells were also green
when HSPCs were injected into the NMDA-damaged eyes of
Nestin-CRE and Nanog-GFP mice, respectively (Figures
2D–2G; Figures S4E and S4F; Tables S2 and S3), indicating
that in the area of damage up to 30% of the hybrids were indeed
reprogrammed, as they had reactivated either Nestin or Nanog
promoters in the neurons.
NMDA has been shown to activate the Wnt pathway in the
retina (Osakada et al., 2007); therefore, to assess the role of acti-
vation of the Wnt/b-catenin signaling pathway in the reprogram-
ming of retinal neurons in both of these mouse models, we also
injected DKK1 immediately after NMDA injection. DKK1 is an
inhibitor of the Wnt pathway (Niida et al., 2004). HSPCs were
transplanted after 24 hr, and mice were sacrificed 24 hr later.
The amount of double-red+/green+-reprogrammed hybrids was
strongly reduced when DKK1 was administered (Figures 2D
and 2G; Figures S4E and S4F; Tables S2 and S3). These results
demonstrated that endogenous and damage-dependent activa-
tion of the Wnt/b-catenin pathway triggers reprogramming of
retinal neurons after their fusion with HSPCs.
Next, we wanted to analyze whether reprogramming of retinal
neurons was increased after transplantation of HSPCs in which
the Wnt signaling pathway had been previously activated using
BIO or by Wnt3a treatment before injection. Surprisingly, 24 hr
after transplantation of BIO-pretreated or Wnt3a-pretreated
HSPCs in NMDA-damaged eyes of the Nestin-Cre and Nanog-
GFP mice, there was a striking increase in the number of
reprogrammed (green+) hybrids with respect to those seen in
NMDA-damaged eyes that received untreated HSPCs (Figures
2D and 2G; Figures S4E and S4F; Tables S2 and S3). Increased
reprogramming after transplantation of BIO-treated HSPCs was
also evaluated and confirmed by FACS analysis (Figure S4G).
Of note, no reprogramming events were seen after the injec-
tion of BIO-treated HSPCs into nondamaged eyes (Figure S4H),
because there was no hybrid formation (Figure S7F, compareeprogramming after HSPC Fusion In Vivo
brids after transplantation of untreated (No BIO, white bars) and BIO-treated
CR quantifications plotted as the fold change with respect to controls from
SPCs or BIO-treated HSPCs. Data are mean ±SEM (n = 6).
or Nanog (E) promoter activation in transgenic mice.
presence of NMDA damage in flat-mounted retinas after transplantation of
ars: 50 mm.
nd Nanog (G) promoters evaluated according to Wnt signaling modulation.
d after 24 hr with either untreated,Wnt3a-treated (Wnt3a), or BIO-treated (BIO)
S2B). ***p < 0.001.
ated cell sorted DiD+/GFP+ hybrids after transplantation of DiD-labeled human
EM (n = 9).
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Figure 3. Reprogrammed Hybrids Can Proliferate and Differentiate
(A) Quantification of mitotic (Ki-67+) and apoptotic (Annexin V+) YFP+ hybrids after transplantation of untreated (No BIO) or BIO-treated (BIO) HSPCsCre in NMDA-
damaged R26Y eyes. Data are mean ±SEM; n = 30. ***p < 0.001.
(B–E) Ki67 (B and D, red) and Annexin V (C and E, red) staining for YFP+ (green)-reprogrammed hybrids obtained 24 hr after injection of BIO-treated (BIO-HSPCs)
or untreated-HSPCsCre in NMDA-damaged R26Y eyes. Nuclei were counterstained with DAPI (blue).
(F and G) Quantification of YFP+ hybrids positive to different markers, as counted after immunostaining of sections (as for Figure S2B) at different times after
transplantation of BIO-treated (F) and untreated (G) HSPCsCre into NMDA-damaged eyes of R26Y mice. Data are mean ±SEM (n = 30).
(legend continued on next page)
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lanes 2 and 4, gray bars), confirming that the tissue damage is
necessary for cell-fusion-mediated retinal neuron reprogram-
ming. All of these data clearly indicate that activation of Wnt
signaling induces a cell-fusion-mediated reprogramming pro-
cess in vivo.
To further confirm the role of b-catenin during in vivo cell
reprogramming upon Wnt signaling activation, in damaged ret-
inas of Nanog-GFP mice, we transplanted HSPCs isolated
from a strain carrying the b-catenin gene flanked by Flox sites.
DiD-labeled HSPCs bcat+/+ were treated with tamoxifen to
delete b-catenin and further left untreated or treated with BIO
(Figures S5A and S5C). Very few reprogramming events were
seen after injection of either the untreated or the BIO-treated
HSPCsbcatflox/flox (Figures S5B and S5D). These results show
that stabilization of b-catenin in the transplanted HSPCs
is essential to allow in vivo reprogramming process after cell
fusion.
Finally, we investigated whether both the retinal neuron
genome and the transplanted HSPC genome underwent reprog-
ramming after fusion. Thus, we transplanted DiD-labeled human
CD34+ HSPCs (hHSPCs) treated with BIO into the damaged
eyes of Nanog-GFP mice to obtain interspecies hybrids (Figures
S6A–S6D). In fluorescence-activated cell sorted DiD+/GFP+
hybrids, there was activation of mouse pluripotent genes, such
as Oct4, Nanog and SSEA1, and of neuronal precursor
genes, such as Nestin, Otx2, Noggin, and Six3; however, the
neuronal-lineage-specific genes Calr and Brn3b and the acti-
vated Mu¨ller glia marker GFAP were downregulated (Figure 2H).
Also, the hHSPC genome underwent reprogramming as some
pluripotency/precursor genes (such as hOct4, hSSEA1, hNestin,
hOtx2, and hNoggin) were activated, while the HSPC marker
hCD34 was downregulated (Figure 2I). These results suggested
that a Wnt-dependent reprogramming process of both genomes
is activated in the hybrids. In addition, lineage genes (such as
hCalr and hGFAP) were activated in the human genome (Fig-
ure 2I), indicating that HSPC nuclei can be reprogrammed and
differentiated toward a neuronal lineage.
Given that it was surprising to observe reprogramming at the
embryonic stage after fusion of HSPCs with neurons, we also
investigated activation of the Nanog-GFP transgene after trans-
plantation of ESCs and RSPCs into NMDA-injured eyes. As
expected, in the case of the ESC transplantation, we observed
reprogramming of the retinal neurons, which was also depen-
dent on activation of the Wnt signaling pathway. DKK1 blocked
reprogramming, while GFP-positive cells were strikingly
increased when ESCs were pretreated with BIO or Wnt3a before
being transplanted (Figures S7A–S7C; Table S4).
To further confirm pluripotency of ESC/retinal-neuron hybrids,
we performed clonal analysis in vitro. NMDA-damaged retinas of
Nanog-GFP-Puromice were transplanted with untreated or BIO-
treated ESCs expressing RFP. Transplanted nondamaged
retinas were used as control. Retinas harvested 24 hr after trans-
plantation were disaggregated and the cells were cultured in(H) YFP+ hybrids (green) obtained 24 hr after transplantation of BIO-treated HS
antibodies (red). Nuclei were counterstained with DAPI.
Scale bars: 50 mm (B, C, D, E, and H).
See also Figure S9.ESC medium under puromycin selection. The cells formed
reprogrammed clones, as they were puromycin resistant and
GFP+, indicating activation of the transgene Nanog promoter
(Figures S8A and S8B). In addition, they were positive for alkaline
phosphatase (AP) staining (Figure S8C) and expressed Oct4 and
Nanog (Figure S8E). A high number of reprogrammed colonies
were selected only from retinas transplanted with BIO-treated
ESCs (Figure S8D). The reprogrammed clones were hybrids,
as they expressed both GFP and RFP (Figures S8A and S8B).
Furthermore they were tetraploid, as 50%of theGFP+ RFP+ cells
contained double DNA content (4n), as evaluated by FACS anal-
ysis (Figures S8F and S8G).
We also transplanted BIO-treated ESCCre in R26Y-damaged
eyes; YFP+ teratomas were seen in mice sacrificed 1month after
transplantation (Figure S7D), which confirmed that reprog-
rammed hybrids could differentiate in different lineages. All these
results showed that the hybrids formed after fusion of BIO-
treated ESCs are reprogrammed and pluripotent. In contrast,
we observed no reprogramming events after injection of RSPCs
into the NMDA-injured eyes of the Nanog-GFP mice, even in the
case of BIO pretreatment of transplanted RSPCs (Figure S7E).
Finally, we also ruled out an effect of BIO in the enhancement
of fusion events in vivo. BIO pretreatment did not enhance the
fusion efficiency of HSPCs, ESCs, or RSPCs injected into the
NMDA-damaged eyes of the R26Y mice (Figure S7F).
In conclusion, here we have shown that activation of the Wnt/
b-catenin signaling pathway triggers the reprogramming of
retinal neurons back to an embryonic/neuronal-precursor stage
and that this occurs following damage-dependent cell-cell
fusion of HSPCs and ESCs but not of RSPCs.
Reprogrammed Hybrids Can Proliferate and
Differentiate In Vivo
Next, we investigated the proliferative potential of the newly
generated hybrids. We injected BIO-treated and untreated
HSPCsCre into the NMDA-damaged eyes of a group of R26Y
mice and retinal sections were analyzed 24 hr later.
BIO treatment led to the formation of mitotic hybrids that
re-entered the cell cycle, as a percentage of the YFP+ cells
were also Ki67+ and BrdU+ (Figures 3A and 3B; Figure S9A);
moreover, only a few YFP+ cells were Annexin V+ and therefore
committed to an apoptotic fate (Figures 3A and 3C). The higher
percentage of BrdU+ hybrids with respect to the Ki67+ hybrids
suggested that the majority of these replicated their DNA and
entered into G0, probably after their differentiation. In contrast,
no proliferation was seen in hybrids formed after injection of
untreated HSPCs, where a high percentage of the hybrids under-
went apoptosis (No BIO; Figures 3A, 3D, and 3E; Figure S9A).
Similar results were obtained after transplantation of BIO-treated
or untreated (No BIO) ESCs (Figure S9B).
Overall, our results show that upon activation of the Wnt/
b-catenin pathway in the transplanted cells, the newly reprog-
rammed hybrids can proliferate through re-entering into thePCsCre in NMDA-damaged R26Y eyes stained with Oct4, Nanog, and Nestin
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cell cycle. In contrast, when Wnt signaling is not activated, the
fate of the hybrids is to embark into apoptosis.
We then analyzed the in vivo differentiation potential of the
reprogrammed retinal neurons of R26Y injectedwith BIO-treated
and untreated HSPCsCre. The mice were sacrificed 24, 48, and
72 hr after transplantation. The percentages of YFP+ hybrids
also positive for each marker were determined from retinal sec-
tions. There were many Oct4-expressing and Nanog-expressing
hybrids 24 and 48 hr after transplantation of BIO-HSPCs, while
these decreased by 72 hr (Figures 3F and 3H). At 24 hr, YFP+
hybrids were already expressing Nestin, Noggin, and Otx2 (neu-
roectoderm), and this expression was maintained at the sub-
sequent times analyzed (48 and 72 hr) (Figures 3F and 3H).
Conversely, the neuronal terminal differentiation marker Tuj-1
and the HSPCmarkers Sca1 and c-Kit were silenced (Figure 3F).
On the other hand, after fusion with untreated HSPCs, a low
number of YFP+ hybrids reactivated Oct4 and Nanog, although
only at 24 hr. These also activated Nestin, Noggin, and Otx2 at
low levels. Instead, themajority of these hybridsmaintained con-
stant expression of Tuj-1, Sca-1, and c-Kit (Figure 3G). Overall,
this indicates activation of a less efficient reprogramming pro-
cess. Both in the absence and presence of BIO treatment, the
mesoderm marker Gata4 and the endoderm marker Hand1
were never expressed (Figures 3F and 3G).
In contrast, after injection of BIO-treated ESCsCre in the
damaged R26Y retinas, a delay in the neuroectodermal differen-
tiation potential of the resulting hybrids (as Nestin, Noggin, and
Otx2 were expressed more at 72 hr, while Oct4 and Nanog
where highly expressed from 24 hr to 72 hr) was seen. Further-
more, the hybrids also expressedGata4 andHand1 (Figure S9C).
Of note, Oct4 and Nanog were poorly expressed in the hybrids
formed after fusion of untreated ESCsCre, while Tuj-1 expression
was maintained, which indicates activation of a poor reprogram-
ming process (Figure S9D).
Thus, we concluded that the BIO-ESC-derived hybrids were
pluripotent, as they can differentiate in mesoderm, endoderm,
and neuroectoderm lineages; in contrast, the BIO-HSPC-
derived hybrids were transiently reprogrammed back to an
embryonic-like state and rapidly embarked into neuroectoderm
differentiation exclusively.
Reprogrammed Hybrids Can Regenerate the Injured
Retina
Having seen that the reprogrammed hybrids can proliferate and
differentiate toward neuroectodermal lineage, we aimed to eval-
uate their long-term differentiation and regenerative potential.
HSPCsCre were pretreated with BIO to activate Wnt signaling
and transplanted into the NMDA-damaged R26Y eyes; un-
treated HSPCsCre were transplanted as the control. The mice
were sacrificed 4 weeks later (Figure 4A). Analysis of flat-
mounted retinas transplanted with BIO-HSPCsCre showed a
high number of YFP+ hybrids (Figure 4B) that were positive for
expression of ganglion (SMI-32) and amacrine (Chat) neuron
markers (Figure 4C).
We then analyzed the optical nerves 24 hr and 1 month after
transplantation. Remarkably, we observed YFP+ axons in the
1-month optical nerves, possibly derived from projections of
the regenerated ganglion neurons (Figures 4B–4D). In contrast,278 Cell Reports 4, 271–286, July 25, 2013 ª2013 The Authorsretinas transplanted with untreated HSPCsCre showed very few
YFP+ hybrids (Figure S10A) with no YFP+ axons along the optical
nerves (Figure 4D, untreated HSPCs). Interestingly, no YFP+
axons were seen in the optical nerves 24 hr after transplantation
of BIO-HSPCs (Figure S10B), which indicates that the newly
generated ganglion neurons project their axons a while after
transplantation, during the regeneration process (Figure 4D).
NMDA treatment induces recruitment of macrophages in the
eye (Sasahara et al., 2008). Indeed, as expected, in retinas har-
vested 24 hr after transplantation, a number of the YFP+ hybrids
were positive to the monocyte/macrophage markers CD45 and
Mac1, which suggested phagocytosis of some transplanted
HSPCsCre/RFP by endogenous macrophages carrying the R26Y
allele or phagocytosis of some YFP+ hybrids themselves (Figures
S10C, S10D, and S10G). Interestingly, these YFP+ hybrids pos-
itive to monocyte/macrophage markers were drastically
decreased in retinas harvested 1 month after transplantation
(Figures S10E–S10G). This indicates that some hybrids can be
phagocytosed soon after transplantation but there remain a suf-
ficient number of hybrids that can regenerate the retinas.
To evaluate the levels of surviving hybrids that regenerate the
retinas, we used FACS analysis to count the YFP+ cells over all
retinal cells both 24 hr after and 1 month after transplantation
of the BIO-treated HSPCsCre in damaged R26Y eyes. We found
up to a 4- to 5-fold increase in the YFP+ cells 1 month after trans-
plantation, which indicated newly generated cells (Figure S10H).
Next, in flat-mounted retinas, we counted the number of YFP+
cells that were positive for the ganglion marker SMI-32. Interest-
ingly, 80% of the YFP+ neurons expressed SMI-32 1 month after
transplantation of the BIO-treated HSPCs, which indicated
regeneration of the retina by differentiation of the hybrids (Fig-
ures 5A and 5B). In addition, expression of the ganglion markers
Calr and Brn3b in the YFP-sorted hybrids was comparable to the
wild-type retina 1 month after transplantation of the BIO-treated
HSPCs (Figure S10I). In contrast, with transplantation of the
untreated HSPCs, there was a drastic drop in the number of
SMI-32+ cells and very little expression of Calr and Brn3b
1 month after transplantation (Figure 5A; Figure S10I). Of note,
and in agreement with previous findings (Otani et al., 2004),
HSPC-transplanted retinas expressed retinal pigment epithe-
lium, indicating a possible transdifferentiation of the untreated
HSPCs toward the epithelial lineage (Figure S10J).
Next, we analyzed the occurrence of neuron regeneration by
histological analysis of retinal vertical sections. Interestingly, in
retinas transplanted with BIO-HSPCs, the number of nuclei in
the ganglion cell layer (Figures 5C and 5D, gcl) and the number
of nuclear rows in the inner nuclear layer (Figures 5C and 5E,
inl) were comparable to wild-type retinas and substantially
increased with respect to nontransplanted retinas and retinas
transplanted with untreated HSPCs (Figures 5C–5E). This indi-
cates retinal regeneration. We also investigated the nuclear
density of the ganglion neurons in the flat-mounted retinas by
counting the total number of ganglion nuclei in the whole retinas
harvested 1 month after transplantation. Remarkably, there was
a significant increase in the number of nuclei in BIO-HSPCsCre–
transplanted retinas, with respect to the nontransplanted retinas
(Figure 5F). However, newly generated ganglion neurons were
not uniformly distributed, as shown by the nuclear density
Figure 4. Long-Term Differentiation Potential of Hybrids Obtained after Cell-Fusion-Mediated Reprogramming
(A) Experimental strategy used to identify YFP+ hybrids 1 month after BIO-treated or untreated HSPCsCre in NMDA-damaged R26Y retinas.
(B) YFP+ neurons were detected in NMDA-injured R26Y retinal flat mounts 1 month after BIO-HSPCsCre transplantation. Nuclei were counterstained with DAPI
(blue). Right: higher magnification of the YFP+ neurons.
(C) YFP+ differentiated hybrids (green) expressing either the ganglion cell marker SMI-32 (left, red) or the amacrine cell marker Chat (right, red).
(D) YFP+ axons (green) detected in optic nerves from eyes transplanted with BIO-HSPCsCre but not with untreated HSPCsCre. Right: higher magnification of the
YFP+ axons (green) in the optic nerve.
Scale bars: 50 mm (B, C, and D) or 200 mm (D).
See also Figure S10.
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Figure 5. NMDA-Damaged Retinas Can Be Regenerated after Fusion of Transplanted BIO-Treated HSPCs
(A and B) Evaluation of the percentage of YFP+ (green) hybrids also positive to SMI-32 staining (red) in flat-mounted retinas harvested 24 hr or 1 month after
transplantation of BIO-treated (BIO, black bars) or untreated (No BIO, gray bars) HSPCsCre in NMDA-damaged R26Y eyes (n = 3). Twenty different random fields
were analyzed for each retina. A representative image of regenerated ganglion cells (yellow arrows) double positive for YFP (green) and SMI-32 (red) is shown in
(B). Scale bar: 50 mm.
(C) Hematoxylin and eosin staining showing increases in thickness of the inner nuclear layer (inl, square brackets) and regeneration of the ganglion cell layer
(gcl, arrowheads) in NMDA-damaged retina 1 month after BIO-HSPCsCre transplantation. Transplantation of untreated HSPCsCre or BIO alone does not induce
regeneration. Arrows indicate ganglion cell loss in the NMDA-damaged retinas. Arrowheads indicate ganglion cell nuclei. Scale bars: 50 mm.
(legend continued on next page)
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maps, which indicated nonhomogenous retinal regeneration
(Figure 5G).
Finally, we also tested whether the injection of BIO and of
Wnt3a without cell transplantation in damaged retinas can
trigger regeneration. We did not find substantial increases in
the numbers of nuclei in the ganglion cell layer and of the nuclear
rows in the inner nuclear layer, and we did not observe increased
numbers of nuclei in the whole flat-mounted retinas (Figures
5C–5G; Figures S10K and S10L). These data demonstrate that
only if Wnt signaling is activated in the transplanted HSPCs
can partial regeneration of the damaged retinal cells be achieved
after fusion of transplanted cells.
Aswe observed regeneration only after transplantation of BIO-
treated HSPCs, we investigated functional rescue in these
regenerated retinas. For this, a group of mice received NMDA
and were either nontransplanted or transplanted with BIO-
treated HSPCs. To test the responses of the ganglion neurons,
we used a multielectrode array that enables simultaneous extra-
cellular recordings from many retinal ganglion cells. Although
there was some variability across different mice, the proportion
of clear light-driven retinal ganglion cells was significantly lower
in damaged retinas than in the control retinas (Figure 6A). In
contrast, the retinas transplanted with BIO-treated HSPCs
showed much higher proportions of ganglion neurons with
light-evoked responses with respect to the NMDA retinas, which
were comparable with the control retinas (Figure 6A).
After uniform flash stimulus, retinal ganglion cells can respond
with an increase in firing rate to the onset of the flash (ON cells),
to the offset (OFF cells), to onset and offset (ON-OFF cells) and
with a firing rate transiently decreased at the onset (SUPRESSED
cells) (Nirenberg andMeister, 1997). Representative examples of
sorted spikes waveforms, raster plots and peristimulus time his-
tograms of the ganglion cells of control, nontransplanted, and
BIO-HSPC-transplanted retinas are shown (Figure 6B). Interest-
ingly, BIO-HSPC-transplanted retinas showed usually spikes of
higher amplitude than NMDA nontransplanted retinas.
Since more than half of the retinal ganglion cells recorded in all
the retinas were ON cells, we examined the response to the light
onset in these cells. ON cells had longer latencies in damaged
retinas than the in control and BIO-treated HSPC transplanted
retinas (p < 0.01). The mean latencies to the ON peak were as
follows (mean ±SD): control, 177.9 ± 29.4 ms; NMDA alone,
234.6 ± 49.1; and NMDA + BIO-HSPCs, 193.6 ± 56.9. The small-
est observation (sampleminimum), lower quartile, median, upper
quartile, and largest observation (sample maximum) of each
sampled group are shown in Figure 6C.
Finally, to study the ganglion cell responses to changing light
intensities, the retinas were randomly stimulated with full-field
flashes with ten different light intensities ranging from black
(0.46 cd/m2) to white (196.3 cd/m2). Our results show that a lower(D and E) Quantification of ganglion nuclei in the ganglion cell layer (D, gcl) and nu
of undamaged or NMDA-damaged retinas treated as in (C). Data are mean ±SEM
(F) All the nuclei excluding those of endothelial cells were counted in the ganglion
as cells per mm2. A total of 80 different images composing the whole retina we
damaged retinas transplanted with BIO-HSPCs and untransplanted damaged re
(G) Total cells in the ganglion cell layer, excluding endothelial cells, counted as in
See also Figure S10.percentage of cells in NMDA-damaged retinas respond to
medium-intensity gray level (corresponding to 35.5 cd/m2) with
respect to control and BIO-HSPC-transplanted retinas
(Figure 6D).
Endogenous BMC Fusion-Mediated Reprogramming
of Retinal Neurons
BMCs are recruited into the eyes upon damage (Sasahara et al.,
2008). We thus investigated whether Wnt-dependent reprog-
ramming of retinal neurons upon fusion with BMCs can occur
as an endogenous process after NMDA damage. We generated
chimeric mice by replacing the BM of sublethally irradiated R26Y
recipient mice with the BM of donor RFP-Cre mice (Figure 7A).
The repopulation of the BM with cells of donor origin was
analyzed (Table S5). NMDA damage was induced in one eye of
each group of chimeric mice, and then 24 hr later the mice
were sacrificed (Figure 7A). Interestingly, after NMDA damage,
some RFP+ BM-derived cells were also YFP+, indicating fusion
of endogenous BMCs recruited into the eyes (Figures 7B and
7C; Figure S11A; Table S6). Various YFP+ hybrids were also
positive for Sca1, Chat, SMI-32, and GS (Figure S11B), which
suggests that endogenous BMCs can also fuse with ganglion,
amacrine, and Mu¨ller cells upon damage. No YFP+/RFP+ cells
were found in undamaged retinas (Figure 7B).
Next, we investigated whether reprogramming can occur after
BMC recruitment and fusion with retinal neurons. Here, we trans-
planted BMCsR26Y into a group of sublethally irradiated Nestin-
Cre mice to generate chimeric mice (Figure 7D). The reactivation
of the Nestin-Cre transgene and the consequent YFP expression
enabled us to identify reprogramming events after BMC recruit-
ment in the eye.
One month after BM replacement, the injection of BIO into
NMDA-damaged eyes of the chimeric mice led to the formation
of YFP+ hybrids, which indicated Nestin promoter reactivation
(Figure 7E). In control eyes, which were not treated with BIO,
no YFP+ hybrids were seen (Figure 7E). Some YFP+ hybrids
were in active mitosis (Figure 7F, Ki67+), and only a few were
dying (Figure 7F, Annexin V+); moreover, some of the hybrids
were positive for Oct4 and Nanog staining, which suggested
reprogramming of retinal neurons after their fusion with recruited
BMCs (Figure 7G; Figure S11C; Table S6). In conclusion, after
recruitment of BMCs, activation of fusion-mediated reprogram-
ming of retinal neurons can occur in the eye if the Wnt pathway
is activated.
DISCUSSION
Here, we have demonstrated that the canonical Wnt/b-catenin
signaling pathway mediates the reprogramming of retinal neu-
rons in vivo. In addition, we have shown that spontaneous cellclear rows in the inner nuclear layer (E, inl) as counted in vertical retinal sections
(n = 30). ***p < 0.001.
cell layer along the nasotemporal (left) and dorsoventral (right) axes and plotted
re counted for each sample. Data are mean ±SEM (n = 3). *p < 0.01 between
tinas. ON, optic nerve.
(F), were plotted as density maps, as indicated in the color key.
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Figure 6. Multielectrode Recordings from Flat-Mounted Mouse Retinas
(A) Percentage of neurons responding or not responding to light in control retinas, NMDA-damaged retinas, and NMDA-damaged retinas transplanted with
BIO-HSPCs. Data are mean ±SEM (n = 5 for each group). ***p < 0.001.
(B) Representative examples of sorted spikes waveforms (top graphs; each color represents a single sorted unit), raster plots of spiking responses, and peri-
stimulus time histograms (PSTHs, bin = 10 ms) (bottom graphs) from typical retinal ganglion cells of control, NMDA-damaged, and NMDA + BIO-HSPC retinas.
(legend continued on next page)
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fusion can occur in the mouse retina after injury and that a pro-
portion of fusion hybrids proliferate if they are reprogrammed
by Wnt activity. Furthermore, we have also shown that if the
hybrids are not reprogrammed, they undergo apoptosis. Surpris-
ingly, the reprogrammed hybrids can regenerate the damaged
retinal tissue, although the regeneration is not homogenous.
Functional rescue of ganglion neurons is also observed in regen-
erated retinas. Finally, we have shown that after exogenous acti-
vation of the Wnt signaling pathway in the eye, BM-derived cells
that are recruited into the injured retina can fuse and reprogram
the retinal neurons.
Adult SPCs can contribute to awide spectrum of differentiated
cells. Transplanted BMCs can fuse and acquire the identity of
liver cells, Purkinje neurons, kidney cells, and epithelial cells.
This plasticity has been ascribed to either transdifferentiation
or cell-cell fusion mechanisms (Frise´n, 2002; Kuc¸i et al., 2009;
Pomerantz and Blau, 2004). To date, however, cell fusion events
have been considered very rare, and therefore the cell identity of
the ‘‘newborn’’ hybrids has never been deeply investigated.
Here, we have demonstrated that cell-cell fusion occurs and
can be visualized as a very relevant event shortly after transplan-
tation of SPCs into a damaged eye. This is true also after mobi-
lization of c-Kit/Sca1-positive cells from the BM into damaged
retinas. In previous studies, the number of hybrids derived
from BMC fusion might have been underestimated; indeed, we
find here that unless these newly formed hybrids are reprog-
rammed, they undergo cell death, and therefore they cannot
be identified a long time after the transplantation. Moreover,
since many hybrids are most likely synkaryons, they cannot be
easily detected in sections.
HSPCs fuse with high efficiency with ganglion and amacrine
neurons; the resulting newborn hybrids are novel cell entities,
and if a Wnt-signaling stimulus is provided, they can initially be
transiently reprogrammed, proliferate, and become terminally
differentiated neurons. It is remarkable that we found expression
of Nanog and Oct4 and, at the same time, expression of Nestin,
Noggin, and Otx2 precursor neuronal markers in these hybrids.
The expression of Nanog and Oct4 is evidence of reprogram-
ming back to the embryonic stage; however, this state is tran-
sient, at least in the case of fusion between HSPCs and retinal
neurons. The hybrids very soon commit to neuroectodermal line-
age, and indeed, 72 hr after transplantation, Oct4 and Nanog
were already downregulated to a certain extent. Finally, in
4 weeks, the hybrids differentiate into ganglion and amacrine
neurons, thereby contributing to the regeneration of the retinal
tissue. Interestingly, we also found YFP+ axons in the optical
nerves 1month after transplantation, which indicates that regen-
erated ganglion neurons can even project their axons along
nerves.
These observations led us to anticipate that Oct4 and Nanog
might have a functional role in adult tissues during cell-fusion-The light ON/dark bar below the histograms represents the light stimulus that was
ON, ON-OFF, and OFF responses are all recorded by the array. Frequency is in
(C) Boxplot latencies to ONpeak including (frombottom to top) the smallest observ
(75th percentile), and largest observation (sample maximum) of each sampled gr
(D) Normalized responses of ON ganglion cells for control, NMDA-damaged, and
shows the mean ±SEM of the percentage of cells responding to each light intenmediated regeneration processes. Expression of these genes
in adults is controversial (Shin et al., 2010); however, it might
well be that their expression has not been clearly appreciated
under some circumstances, probably because it is very
transient.
In extremely rare cases, we found expression of GFP, and
therefore of the Nanog transgene, without expression of RFP.
This result was unexpected andmight have arisen from the acci-
dental silencing of the RFP allele in the hybrids or from fusion-
mediated reprogramming after mobilization of endogenous
BM-derived cells.
ESCs have great plasticity, and here we have identified the
dedifferentiation events in vivo; i.e., reprogrammed hybrids ex-
pressing Nanog after the fusion of retinal neurons with ESCs.
ESC/retinal-neuron hybrids are probably fully reprogrammed,
as they can differentiate into the three lineages, a feature that
HSPC-derived hybrids do not have. ESC-derived hybrids can
form reprogrammed clones in culture and form teratoma in vivo.
In contrast, in vitro, we were not able to isolate clones from
HSPC/retinal-neuron hybrids, which is consistent with their
transient reprogramming and fast commitment to neuroecto-
derm lineage differentiation. Interestingly, reprogramming of
retinal neurons was not observed after fusion of RSPCs, which
indicates the lower degree of plasticity of these cells with respect
to HSPCs. However, we cannot exclude that pluripotent cells are
poorly enriched in our RSPC preparation.
Recently, it has been shown that cardiac fibroblasts can be
reprogrammed by overexpression of specific transcription fac-
tors in vivo, which results in an improvement of cardiac function
in mice (Qian et al., 2012; Song et al., 2012). However, to date,
neuron dedifferentiation in vivo has been considered as relatively
difficult. Here, we have demonstrated that neurons can indeed
change their developmental stage in a living organism while resi-
dent in their own tissue. However, when they fuse with HSPCs,
they keep the memory of their neuronal identity, as these
newborn hybrids finally differentiate into neurons.
To track in vivo reprogramming events is not easy; indeed,
these events are transient. Furthermore, ESCs, in principle, do
not exist in the embryo or exist for only a few hours. Pluripotent
cells, such as the reprogrammed cells, should rapidly undergo a
change of fate in vivo, which will depend on the different tissue
signals and their commitment to progress into a specific differen-
tiation fate. A lineage identity memory that is not erased during
the reprogramming processmight be beneficial to direct the cor-
rect differentiation path in vivo. Interestingly, induced pluripotent
stem cells have been shown to retain epigenetic memory of their
somatic cells of origin (Kim et al., 2010; Polo et al., 2010). Here, in
our model, the transition from one cell differentiation stage to
another is not direct but passes through the transient re-expres-
sion of precursor genes, thereby passing through an intermedi-
ate, less-differentiated developmental precursor.generated from a computer monitor and was projected onto the retinal surface.
impulses (spikes) per second.
ation (sampleminimum), lower quartile (25th percentile), median, upper quartile
oup.
NMDA + BIO HSPC retinas as a function of stimulus intensity. Each data point
sity ranging from black to white (boxes).
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Figure 7. Endogenous BM-Derived Cells Recruited in Damaged Eyes Can Fuse with Retinal Neurons
(A) Experimental scheme of endogenous BMC-fusion detection. R26Y mice received BMRFP/Cre transplantation. After BM reconstitution (1 month), the right eyes
received an intravitreal injection of NMDA and the left eyes were not injected. The mice were analyzed 24 hr later. Only in the case of cell fusion of recruited BM
cells (red) and neurons were YFP/RFP double-positive hybrids detected.
(B) Double-positive YFP/RFP hybrids detected in NMDA-damaged (NMDA) but not in healthy (control) eyes. Scale bar: 50 mm.
(C) Quantification of percentage of YFP+ hybrids with respect to the total number of detected RFP cells (calculated as for Figure S2B). Data are mean ±SEM.
***p < 0.001.
(D) Experimental scheme of endogenous cell-fusion-mediated reprogramming. Nestin-Cre mice received BMR26Y transplantation. After BM reconstitution
(1 month), the right eyes received an intravitreal injection of BIO + NMDA, while the contralateral eyes were injected with NMDA alone. Nestin-mediated Cre
expression leads to expression of the YFP only in the case of cell-fusion-mediated reprogramming of hybrids between recruited BMCsR26Y and neurons.
(E) YFP+ reprogrammed hybrids (green) after fusion of recruited BMCs and damaged neurons were detected only after BIO injection (NMDA+BIO). In contrast, no
YFP+ hybrids were seen in NMDA-damaged eyes without BIO (NMDA). Scale bar: 50 mm.
(F and G) Quantification of percentages of mitotic (Ki67+) or apoptotic (Annexin V+) hybrids (F) and Oct4-positive and Nanog-positive hybrids (G), evaluated with
the respect to the total number of YFP+ cells. Data are mean ±SEM (n = 30).
See also Figure S11.
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Wnt signaling controls the regeneration of tissues in response
to damage in lower eukaryotes (Lengfeld et al., 2009). Regener-
ation of the zebrafish tail fin and Xenopus limbs requires activa-
tion of Wnt/b-catenin signaling (Lin and Slack, 2008); likewise for
tissue regeneration in planarians (De Robertis, 2010). Interest-
ingly, in fish and postnatal chicken retina, downregulation of
Mu¨ller-cell-specific markers, such as glutamine synthetase,
and activation of progenitor markers, such as Pax6 and Chx10,
have been associated with a regenerative potential of these cells
(Fischer, 2005). The regenerative response in zebrafish retina
was shown to be due to Mu¨ller glia dedifferentiation, which
re-expresses pluripotency factors (Ramachandran et al., 2010).
However, exogenous activation of Wnt signaling is necessary
to induce Mu¨ller cell dedifferentiation in mouse retina (Osakada
et al., 2007). The Wnt signaling regenerative activity that is pre-
sent in lower eukaryotes might therefore have been lost during
evolution.
Although all of these studies highlight the important role of the
Wnt/b-catenin signaling pathway in the regeneration process,
the biological mechanisms that form the basis of this regenera-
tion were still largely unknown to date. Here, we have shown
that at least in mouse retina, regeneration can occur through
cell-fusion-mediated reprogramming. On the other hand, there
is nonhomogenous regeneration of the transplanted retinas,
which indicates that other factors might be used to enhance
these processes (e.g., nerve growth factors). Nevertheless, the
main features of the electrophysiological responses of regener-
ated retinas were similar to wild-type control retinas indicating
that cell-fusion-mediated reprogramming has a potential to be
a therapeutic approach. However, we cannot exclude that in
addition to the generation of new neurons, and therefore the
bona fide regeneration of the retinal tissue, we might have also
induced delayed neuronal degeneration.
It is also interesting to note that the regeneration process
cannot be induced by modulation of Wnt signaling pathway
alone; in fact, cell-fusion-mediated reprogramming is also
essential. Therefore, it can be therapeutically relevant to imple-
ment strategies to increase BMC recruitment to the eyes along
with the activation of Wnt signaling. We observed that BMCs
fuse with Mu¨ller cells after damage; therefore, it might be that
the Wnt-dependent dedifferentiation of Mu¨ller cells that has
been reported previously in mouse retina (Osakada et al.,
2007) is also contributed by fusion events with recruited BMCs.
The endogenous in vivo reprogramming can be a mechanism
of damage repair, and minor cellular damages might be repaired
through cell-fusion-mediated reprogramming after the recruit-
ment of BMCs. It is also possible that Wnt-mediated reprogram-
ming is a safeguard mechanism after in vivo cell fusion. The
hybrids that are not reprogrammed undergo apoptosis-medi-
ated cell death. Instead, Wnt-mediated reprogrammed hybrids
can survive and proliferate.
There are obviously many questions still open. For example,
do the newborn hybrids maintain the double genome content?
And if so, do they silence one of the two genome copies? Or
alternatively, might the nuclei divide, or is one of the two nuclei
excised by the hybrids in a very early stage after fusion?
We found double DNA content in the sorted hybrids. Also, we
detected the expression of RFP and YFP transgenes derivedfrom the genomes of the two different fusion partners, which in-
dicates contributions of both genomes in the hybrids. Moreover,
we observed proliferation of the reprogrammed hybrids, an indi-
cation that they were mononucleate cells or bona fide syn-
karyons. However, we also found some heterokaryons shortly
after fusion. Stable heterokaryons have been seen with Purkinje
cell fusion with BM-derived cells, and their numbers were greatly
increased upon inflammation (Johansson et al., 2008). In addi-
tion, tetraploid cells have also been found recently in wild-type
chicken retinas (Morillo et al., 2010). The exact percentages of
synkaryons, heterokaryons, andmononucleated neurons remain
to be defined.
In conclusion, after Wnt signaling activation, retinal neurons
can be reprogrammed after cell fusion with BMCs and the
hybrids can contribute to cell regeneration and repair of retinal
tissue. Ultimately, this mechanism can be exploited for regener-
ative medicine approaches.
EXPERIMENTAL PROCEDURES
Retinal Damage and Drug Treatment
Mice at the age of 3 months were anaesthetized by an intraperitoneal injection
of ketamine: medetomidine (80 mg/kg: 1.0 mg/kg). To induce retinal damage,
the mice were treated intravitreally with 2 ml 20 mmol NMDA (Timmers et al.,
2001) (total 40 nmol; Sigma) for 24 hr. To block endogenous activation of
Wnt signaling, 2 ml DKK1 (5 mg/ml) was injected soon after the NMDA treatment.
Control eyes received 2 ml PBS. For the BrdU incorporation assays, the mice
received intraperitoneal BrdU administration at 50 mg/kg body weight every
6 hr for 24 hr.
For further details, please refer to Extended Experimental Procedures and
Table S7.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, 11
figures, and 7 tables and can be found with this article online at http://dx.
doi.org/10.1016/j.celrep.2013.06.015.
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